Autopsy report · NCT02247687

Management of Participants With Low-level Persistent Viremia (ANRS 161 L-VIR)

“Low recruitment of participants for the study”

The sponsor’s own words in the registry.

Life of this trial

• Registered 3 months before it started.
• Ran for about 9 months before it stopped.
• 4 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Phase 3

Sponsor

ANRS, Emerging Infectious Diseases

Sponsor type

Government (non-US federal)

Conditions

HIV-1 Infection; Treatment Resistant Disorders; Viremia

Interventions

Protease inhibitor; Isentress® (raltegravir); Counseling arm

Participants

4

Sites

20

Countries

France

Trials that died the same way

• Calcium, Vitamin D and Metformin to Treat Insulin Resistance in Obese African American Adolescent Females
  “Poor recruitment to the study” (87% match in meaning)
• Imaging Location of Hamstring Muscle Lesions in Sport and Relationships With Injury Mechanism.
  “Reduced recruitment potential for study participants.” (85% match in meaning)
• SMS-based Lifestyle Intervention for Patients With Liver Cirrhosis With Previous Hepathic Encephalopathy
  “Slow recruitment of study participants” (85% match in meaning)
• Normal Pressure Hydrocephalus Treatment by Acetazolamide
  “difficulty in recruiting participants to the study” (83% match in meaning)
• Randomized, Blinded, Sham-controlled Trial of Acupuncture for the Management of Joint Pain in Patients With Psoriasis
  “Not enough study participants, difficulties in recruitment” (82% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.